跳至主要内容
临床试验/CTRI/2024/11/076415
CTRI/2024/11/076415招募中不适用

A Clinico-Pathological study of Sickle Cell Anemia WSR to Sannipatika Pandu and Management by Poly Herbal Formulation with Standard Care

Self1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年12月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
Self
入组人数
100
试验地点
1
主要终点
Poly herbal formulation(Trial drug) is effective in treating Sickle Cell Anaemia Stabilisation.

研究概览

简要总结

The clinical trial on the management of Sickle Cell Anaemia by Poly herbal formulation with standard care of Hydroxyurea has been started from 7th November 2025 and till date 32 participants have registered in this clinical trial.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
12.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Having Clinical Sign and Symptoms of SCD.
  • (as per VAS score) and Vaso-occlusive events 1-10 in past 12 months.

排除标准

  • Heterozygous sickle cell disease(HbAS).

结局指标

主要结局

Poly herbal formulation(Trial drug) is effective in treating Sickle Cell Anaemia Stabilisation.

时间窗: One year

次要结局

  • Poly herbal formulation is more effective than Hydroxyurea(Control drug) for Prophylactic management of Sickle Cell Anaemia .(Poly herbal formulation is more effective than Hydroxyurea(Control drug) for Prophylactic management of Sickle Cell Anaemia .)

研究者

发起方
Self
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Harish Chandra Giri

Sri Sri College of ayurvedic science and research hospital

研究点 (1)

Loading locations...

相似试验

Treatment of Sickle cell Anemia by Herbal medicines | 临床试验